No significant effect of 7,8-dihydroxyflavone on APP processing and Alzheimer-associated phenotypes.
Identifieur interne : 000454 ( PubMed/Checkpoint ); précédent : 000453; suivant : 000455No significant effect of 7,8-dihydroxyflavone on APP processing and Alzheimer-associated phenotypes.
Auteurs : Weitao Zhou ; Xiaoyong Li ; Daochao Huang ; Weihui Zhou ; Tingyu Li ; Weihong Song [République populaire de Chine]Source :
- Current Alzheimer research [ 1875-5828 ] ; 2015.
English descriptors
- KwdEn :
- Alzheimer Disease (genetics), Amyloid beta-Peptides (metabolism), Amyloid beta-Protein Precursor (genetics), Amyloid beta-Protein Precursor (metabolism), Animals, Antipsychotic Agents (therapeutic use), Cells, Cultured, Disease Models, Animal, Dose-Response Relationship, Drug, Enzyme-Linked Immunosorbent Assay, Flavones (therapeutic use), HEK293 Cells, Humans, Maze Learning (drug effects), Mice, Mice, Transgenic, Mutation (genetics), Peptide Fragments (metabolism), Presenilin-1 (genetics), RNA, Messenger (metabolism), Time Factors, Transfection.
- MESH :
- chemical , genetics : Amyloid beta-Protein Precursor, Presenilin-1.
- chemical , metabolism : Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Peptide Fragments, RNA, Messenger.
- drug effects : Maze Learning.
- genetics : Alzheimer Disease, Mutation.
- chemical , therapeutic use : Antipsychotic Agents, Flavones.
- Animals, Cells, Cultured, Disease Models, Animal, Dose-Response Relationship, Drug, Enzyme-Linked Immunosorbent Assay, HEK293 Cells, Humans, Mice, Mice, Transgenic, Time Factors, Transfection.
Abstract
It is reported that 7,8-dihydroxyflavone (DHF), a TrkB agonist, has beneficial effects on neuronal excitotoxicity, stroke, and Parkinson disease in animal models by enhancing axon regeneration, muscle reinnervation and neuromuscular transmission. The effect of DHF on AD neuropathology remains not well defined. In this study we examined whether DHF affects APP processing and cognitive functions in vitro and in vivo. We found that DHF had no significant effect on amyloid β precursor protein (APP), BACE1 and amyloid β protein (Aβ). DHF had little effect on APP processing in cell cultures. DHF treatment did not reduce the deposition of Aβ to form neuritic plaques in the brain of AD model mice APP23/PS45. Furthermore, DHF did not alleviate learning and memory impairments in the AD model mice. Our study suggest that further extensive and careful studies are warranted for considering DHF as a new therapeutic agent for reducing amyloid pathology and alleviating cognitive deficits for AD treatment.
PubMed: 25523427
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25523427Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">No significant effect of 7,8-dihydroxyflavone on APP processing and Alzheimer-associated phenotypes.</title><author><name sortKey="Zhou, Weitao" sort="Zhou, Weitao" uniqKey="Zhou W" first="Weitao" last="Zhou">Weitao Zhou</name></author><author><name sortKey="Li, Xiaoyong" sort="Li, Xiaoyong" uniqKey="Li X" first="Xiaoyong" last="Li">Xiaoyong Li</name></author><author><name sortKey="Huang, Daochao" sort="Huang, Daochao" uniqKey="Huang D" first="Daochao" last="Huang">Daochao Huang</name></author><author><name sortKey="Zhou, Weihui" sort="Zhou, Weihui" uniqKey="Zhou W" first="Weihui" last="Zhou">Weihui Zhou</name></author><author><name sortKey="Li, Tingyu" sort="Li, Tingyu" uniqKey="Li T" first="Tingyu" last="Li">Tingyu Li</name></author><author><name sortKey="Song, Weihong" sort="Song, Weihong" uniqKey="Song W" first="Weihong" last="Song">Weihong Song</name><affiliation wicri:level="1"><nlm:affiliation>Department of Psychiatry, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; Fax: 604-822-7756; or Children's Hospital of Chongqing Medical University, Chongqing 400014, China. weihong@mail.ubc.ca.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Psychiatry, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; Fax: 604-822-7756; or Children's Hospital of Chongqing Medical University, Chongqing 400014</wicri:regionArea><wicri:noRegion>Chongqing 400014</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25523427</idno><idno type="pmid">25523427</idno><idno type="wicri:Area/PubMed/Corpus">000592</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000592</idno><idno type="wicri:Area/PubMed/Curation">000592</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000592</idno><idno type="wicri:Area/PubMed/Checkpoint">000592</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000592</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">No significant effect of 7,8-dihydroxyflavone on APP processing and Alzheimer-associated phenotypes.</title><author><name sortKey="Zhou, Weitao" sort="Zhou, Weitao" uniqKey="Zhou W" first="Weitao" last="Zhou">Weitao Zhou</name></author><author><name sortKey="Li, Xiaoyong" sort="Li, Xiaoyong" uniqKey="Li X" first="Xiaoyong" last="Li">Xiaoyong Li</name></author><author><name sortKey="Huang, Daochao" sort="Huang, Daochao" uniqKey="Huang D" first="Daochao" last="Huang">Daochao Huang</name></author><author><name sortKey="Zhou, Weihui" sort="Zhou, Weihui" uniqKey="Zhou W" first="Weihui" last="Zhou">Weihui Zhou</name></author><author><name sortKey="Li, Tingyu" sort="Li, Tingyu" uniqKey="Li T" first="Tingyu" last="Li">Tingyu Li</name></author><author><name sortKey="Song, Weihong" sort="Song, Weihong" uniqKey="Song W" first="Weihong" last="Song">Weihong Song</name><affiliation wicri:level="1"><nlm:affiliation>Department of Psychiatry, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; Fax: 604-822-7756; or Children's Hospital of Chongqing Medical University, Chongqing 400014, China. weihong@mail.ubc.ca.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Psychiatry, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; Fax: 604-822-7756; or Children's Hospital of Chongqing Medical University, Chongqing 400014</wicri:regionArea><wicri:noRegion>Chongqing 400014</wicri:noRegion></affiliation></author></analytic><series><title level="j">Current Alzheimer research</title><idno type="eISSN">1875-5828</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alzheimer Disease (genetics)</term><term>Amyloid beta-Peptides (metabolism)</term><term>Amyloid beta-Protein Precursor (genetics)</term><term>Amyloid beta-Protein Precursor (metabolism)</term><term>Animals</term><term>Antipsychotic Agents (therapeutic use)</term><term>Cells, Cultured</term><term>Disease Models, Animal</term><term>Dose-Response Relationship, Drug</term><term>Enzyme-Linked Immunosorbent Assay</term><term>Flavones (therapeutic use)</term><term>HEK293 Cells</term><term>Humans</term><term>Maze Learning (drug effects)</term><term>Mice</term><term>Mice, Transgenic</term><term>Mutation (genetics)</term><term>Peptide Fragments (metabolism)</term><term>Presenilin-1 (genetics)</term><term>RNA, Messenger (metabolism)</term><term>Time Factors</term><term>Transfection</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Amyloid beta-Protein Precursor</term><term>Presenilin-1</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Amyloid beta-Peptides</term><term>Amyloid beta-Protein Precursor</term><term>Peptide Fragments</term><term>RNA, Messenger</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Maze Learning</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Alzheimer Disease</term><term>Mutation</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antipsychotic Agents</term><term>Flavones</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Cells, Cultured</term><term>Disease Models, Animal</term><term>Dose-Response Relationship, Drug</term><term>Enzyme-Linked Immunosorbent Assay</term><term>HEK293 Cells</term><term>Humans</term><term>Mice</term><term>Mice, Transgenic</term><term>Time Factors</term><term>Transfection</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">It is reported that 7,8-dihydroxyflavone (DHF), a TrkB agonist, has beneficial effects on neuronal excitotoxicity, stroke, and Parkinson disease in animal models by enhancing axon regeneration, muscle reinnervation and neuromuscular transmission. The effect of DHF on AD neuropathology remains not well defined. In this study we examined whether DHF affects APP processing and cognitive functions in vitro and in vivo. We found that DHF had no significant effect on amyloid β precursor protein (APP), BACE1 and amyloid β protein (Aβ). DHF had little effect on APP processing in cell cultures. DHF treatment did not reduce the deposition of Aβ to form neuritic plaques in the brain of AD model mice APP23/PS45. Furthermore, DHF did not alleviate learning and memory impairments in the AD model mice. Our study suggest that further extensive and careful studies are warranted for considering DHF as a new therapeutic agent for reducing amyloid pathology and alleviating cognitive deficits for AD treatment.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25523427</PMID><DateCreated><Year>2015</Year><Month>01</Month><Day>08</Day></DateCreated><DateCompleted><Year>2015</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2015</Year><Month>01</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-5828</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Current Alzheimer research</Title><ISOAbbreviation>Curr Alzheimer Res</ISOAbbreviation></Journal><ArticleTitle>No significant effect of 7,8-dihydroxyflavone on APP processing and Alzheimer-associated phenotypes.</ArticleTitle><Pagination><MedlinePgn>47-52</MedlinePgn></Pagination><Abstract><AbstractText>It is reported that 7,8-dihydroxyflavone (DHF), a TrkB agonist, has beneficial effects on neuronal excitotoxicity, stroke, and Parkinson disease in animal models by enhancing axon regeneration, muscle reinnervation and neuromuscular transmission. The effect of DHF on AD neuropathology remains not well defined. In this study we examined whether DHF affects APP processing and cognitive functions in vitro and in vivo. We found that DHF had no significant effect on amyloid β precursor protein (APP), BACE1 and amyloid β protein (Aβ). DHF had little effect on APP processing in cell cultures. DHF treatment did not reduce the deposition of Aβ to form neuritic plaques in the brain of AD model mice APP23/PS45. Furthermore, DHF did not alleviate learning and memory impairments in the AD model mice. Our study suggest that further extensive and careful studies are warranted for considering DHF as a new therapeutic agent for reducing amyloid pathology and alleviating cognitive deficits for AD treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Weitao</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaoyong</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Daochao</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Weihui</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tingyu</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Weihong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; Fax: 604-822-7756; or Children's Hospital of Chongqing Medical University, Chongqing 400014, China. weihong@mail.ubc.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>TAD-117948</GrantID><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Alzheimer Res</MedlineTA><NlmUniqueID>101208441</NlmUniqueID><ISSNLinking>1567-2050</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C485383">6,7-dihydroxyflavone</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047309">Flavones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508853">PSEN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053764">Presenilin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C078592">amyloid beta-protein (1-40)</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C075222">amyloid beta-protein (1-42)</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047309" MajorTopicYN="N">Flavones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018782" MajorTopicYN="N">Maze Learning</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053764" MajorTopicYN="N">Presenilin-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>08</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>11</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25523427</ArticleId><ArticleId IdType="pii">CAR-EPUB-64074</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>République populaire de Chine</li></country></list><tree><noCountry><name sortKey="Huang, Daochao" sort="Huang, Daochao" uniqKey="Huang D" first="Daochao" last="Huang">Daochao Huang</name><name sortKey="Li, Tingyu" sort="Li, Tingyu" uniqKey="Li T" first="Tingyu" last="Li">Tingyu Li</name><name sortKey="Li, Xiaoyong" sort="Li, Xiaoyong" uniqKey="Li X" first="Xiaoyong" last="Li">Xiaoyong Li</name><name sortKey="Zhou, Weihui" sort="Zhou, Weihui" uniqKey="Zhou W" first="Weihui" last="Zhou">Weihui Zhou</name><name sortKey="Zhou, Weitao" sort="Zhou, Weitao" uniqKey="Zhou W" first="Weitao" last="Zhou">Weitao Zhou</name></noCountry><country name="République populaire de Chine"><noRegion><name sortKey="Song, Weihong" sort="Song, Weihong" uniqKey="Song W" first="Weihong" last="Song">Weihong Song</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000454 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000454 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:25523427
|texte= No significant effect of 7,8-dihydroxyflavone on APP processing and Alzheimer-associated phenotypes.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25523427" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |